| DAA840 |
Reduction in small intestine absorption rate |
Physiological |
small intestine |
Human |
— |
— |
|
| DAA1528 |
regulation of nuclear pre-mRNA domain containing 1B |
Molecular |
liver |
Mouse |
Rprd1b |
10.0% Increase Gene Expression Level |
|
| DAA859 |
Responsiveness of cholinergic receptors is decreased |
Physiological |
ileum |
Human |
— |
— |
|
| DAA861 |
Resting and squeeze pressures in anal canal decrease |
Physiological |
anus |
Human |
— |
— |
|
| DAA1516 |
retinol binding protein 1, cellular |
Molecular |
liver |
Mouse |
Rbp1 |
33.0% Increase Gene Expression Level |
|
| DAA1543 |
Rho GDP dissociation inhibitor (GDI) alpha |
Molecular |
liver |
Mouse |
Arhgdia |
9.0% Increase Gene Expression Level |
|
| DAA1510 |
ribosomal protein L37 |
Molecular |
liver |
Mouse |
Rpl37 |
4.0% Increase Gene Expression Level |
|
| DAA1557 |
ribosome binding protein 1 |
Molecular |
liver |
Mouse |
Rrbp1 |
6.0% Increase Gene Expression Level |
|
| DAA1554 |
RIKEN cDNA 1110002B05 gene |
Molecular |
liver |
Mouse |
1110002B05Rik |
5.0% Increase Gene Expression Level |
|
| DAA827 |
Slowing down of peristaltic motion in alimentary canal |
Physiological |
alimentary system |
Human |
— |
— |
|
| DAA1514 |
squalene epoxidase |
Molecular |
liver |
Mouse |
Sqle |
26.0% Increase Gene Expression Level |
|
| DAA1547 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
Molecular |
liver |
Mouse |
St3gal3 |
25.0% Increase Gene Expression Level |
|
| DAA592 |
Stomach cancer |
Pathological |
stomach |
Human |
— |
SeriesMorbidity |
|
| DAA1201 |
TCF4 exon 1 methylation increases |
Molecular |
gastric mucosa |
Human |
TCF4 |
Increase DNA Methylation |
|
| DAA849 |
telomere shortening |
Molecular |
liver |
Human |
— |
— |
|
| DAA862 |
Threshold sensational level for rectal filling increase |
Physiological |
rectum, anus |
Human |
— |
— |
|
| DAA862 |
Threshold sensational level for rectal filling increase |
Physiological |
rectum, anus |
Human |
— |
— |
|
| DAA1529 |
trefoil factor 3, intestinal |
Molecular |
liver |
Mouse |
Tff3 |
97.0% Increase Gene Expression Level |
|
| DAA1515 |
tripartite motif-containing 43A |
Molecular |
liver |
Mouse |
Trim43a |
5.0% Decrease Gene Expression Level |
|
| DAA1061 |
Variability in clearance of hepatically metabolized drugs |
Physiological |
liver |
Human |
— |
— |
|
| DAA588 |
Viral hepatitis |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
| DAA846 |
Weakening of intestinal wall |
Physiological |
large intestine |
Human |
— |
— |
|
| DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|